European Alliance for Personalised Medicine

EAPM Reflects
How to build resilient health systems after COVID-19.
EAPM’S 8th Annual Conference Report
"Defining the healthcare ecosystem to determine value”
CONGRESS REPORT
EAPM 3rd Annual Congress: 'Forward together with innovation: The importance of policy making in the era of personalised medicine'
EAPM report ESMO Roundtable:
"Bringing innovation into EU healthcare system"
Briefing for Members of the European Parliament

September 2019
EAPM 2019 Interviews - Members of the European Parliament (MEPs) & Stakeholders
EAPM Presidency Conference Report, 2019 - Now Available!
EAPM Congress Report 2018
Declaration of Cooperation
Towards access to at least 1 million sequenced genomes in the European Union by 2022.
FROM HERE TO 2025

personalised medicine and healthcare for an immediate future.
EAPM briefing document on IVD regulation
As an outcome of the September 14th EAPM Stakeholder meeting on in-vitro diagnostic, please see the EAPM briefing document.
Barrier Access
Despite its many tangible advantages, the take-up in Europe has been relatively slow. This is not because personalised medicine doesn’t work – it does, and very well - but it is because the components and interactions involved in bring individualised medicine and treatments to Europe’s citizens are complex. But bring it we must, as a healthier Europe will mean healthier citizens.

EUROPEAN ALLIANCE FOR PERSONALIZED MEDICINE

EDUCATION OF HEALTHCARE PROFESSIONALS

TRANSLATIONAL RESEARCH

REGULATORY AFFAIRS

ACCESS / VALUE OF INNOVATION

SMART - OUTREACH

Register for Conference

EAPM Congress 2017 Registration

SOCIAL MEDIA

TWITTER

EVENTS

Maintaining Public Trust in use of Big Data for Health Science in a Covid and Post Covid World
congress
30 Jun 2020

» All incoming events
» Events archive

MEMBERSHIP FORM

Copyright © European Alliance for Personalised Medicine. All rights reserved.

Privacy statement | Contact